(VIANEWS) – ABN AMRO BANK N.V. (ABN.AS), SPAREBANK 1 SØRØ (SOON.OL), MEDISTIM (MEDI.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ABN AMRO BANK N.V. (ABN.AS)
20% sales growth and 9.3% return on equity
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.23.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 6.84. Meaning, the purchaser of the share is investing €6.84 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.3%.
Moving Average
ABN AMRO BANK N.V.’s value is above its 50-day moving average of €14.22 and way above its 200-day moving average of €13.64.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €15.25 at 22:20 EST, way under its 52-week high of €17.00 and way higher than its 52-week low of €8.69.
More news about ABN AMRO BANK N.V..
2. SPAREBANK 1 SØRØ (SOON.OL)
18.8% sales growth and 10.73% return on equity
SpareBank 1 Sørøst-Norge provides various banking products and services for private and corporate customers in Norway. The company offers mobile and online banking, card, account, and payment services. It also provides mortgage, car, boat, consumer, and other vehicle loans as well as refinancing, micro savings, investment, pension, and property related services. In addition, the company offers daily operations, get paid, loans and financing, and pension related products. Further, it provides business and personnel insurance as well as savings and investment products. The company was founded in 1859 and is headquartered in Sandefjord, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SØRØ has a trailing twelve months EPS of kr4.79.
PE Ratio
SPAREBANK 1 SØRØ has a trailing twelve months price to earnings ratio of 10.38. Meaning, the purchaser of the share is investing kr10.38 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.73%.
Moving Average
SPAREBANK 1 SØRØ’s worth is under its 50-day moving average of kr50.43 and below its 200-day moving average of kr52.27.
Sales Growth
SPAREBANK 1 SØRØ’s sales growth for the next quarter is 18.8%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 31, 2023, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 5.22%.
Volume
Today’s last reported volume for SPAREBANK 1 SØRØ is 9247 which is 62.78% below its average volume of 24847.
More news about SPAREBANK 1 SØRØ.
3. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.3.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 41.43. Meaning, the purchaser of the share is investing kr41.43 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
More news about MEDISTIM.
4. PARETO BANK (PARB.OL)
11.4% sales growth and 14.03% return on equity
Pareto Bank ASA provides various banking products and services in Norway. The company accepts corporate deposits. It also offers corporate financing; receivables financing; residential and commercial financing for land and property; ship financing, including corporate and project financing; and other private or housing loans. Pareto Bank ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PARETO BANK has a trailing twelve months EPS of kr7.86.
PE Ratio
PARETO BANK has a trailing twelve months price to earnings ratio of 6.62. Meaning, the purchaser of the share is investing kr6.62 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.
More news about PARETO BANK.
